東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

Epigenetic Regulation of Hepatitis B...

Collopy, Rachel Matrenec,

FindBook

Google Book

Amazon

博客來

Epigenetic Regulation of Hepatitis B Virus In Vivo /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Epigenetic Regulation of Hepatitis B Virus In Vivo // Rachel Matrenec Collopy.
作者:	Collopy, Rachel Matrenec,
面頁冊數:	1 electronic resource (106 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-04, Section: B.
Contained By:	Dissertations Abstracts International86-04B.
標題:	Virology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31693775
ISBN:	9798384461111

Epigenetic Regulation of Hepatitis B Virus In Vivo /
Collopy, Rachel Matrenec,

Epigenetic Regulation of Hepatitis B Virus In Vivo /Rachel Matrenec Collopy. - 1 electronic resource (106 pages)

Source: Dissertations Abstracts International, Volume: 86-04, Section: B.

Chronic hepatitis B virus (HBV) infection is a global public health concern responsible for nearly 1 million deaths annually. Current mainstays of HBV treatment, nucleoside analogs and interferon, are associated with drug resistance and negative side effects. Most importantly, these treatments are not curative and only slow the progression of chronic HBV, which frequently leads to significant liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Chronic HBV infection is maintained by viral covalently closed circular (ccc) DNA, a highly stable replication product and transcriptional template which exists as an episome in the nucleus. As such, the epigenetic silencing of nuclear HBV DNA represents one potential mechanism that may address curing chronic HBV infection. The limited coding capacity of the virus leaves few viral drug targets. As such, targeting host cellular factors that contribute to successful HBV replication is imperative. This current study explores the roles of Foxa and Ten-eleven translocation (Tet) methylcytosine dioxygenases in the epigenetic regulation of HBV DNA.Liver-specific Foxa- and Tet-deficient HBV transgenic mice are useful in vivo models of chronic HBV infection. HBV cccDNA is associated with histones and assembled into chromatin in patients. It is likely subject to regulation similar to that of the HBV transgene in this mouse model. Liver-specific Foxa-deficient HBV transgenic mice do not replicate HBV due to the specific transcriptional silencing of the viral DNA as a result of methylation. The methylation of the HBV DNA is observed in these mice regardless of which Foxa factor is deleted, suggesting that the level of Foxa factor activity governs the demethylation of the HBV transgene, rather than the expression of any specific Foxa factor. Similarly, Tet-deficient HBV transgenic mice display high levels of viral DNA methylation and very low levels of viral transcription and replication. Together, these observations suggest that Foxa and/or Tet enzymes are viable drug targets that may offer resolution of chronic HBV infection.

English

ISBN: 9798384461111Subjects--Topical Terms:

642304
Virology.
Subjects--Index Terms:

Hepatitis B virus

Epigenetic Regulation of Hepatitis B Virus In Vivo /
LDR:03675nmm a22004693i 4500 001 2437542
005 20251124054801.5
006 m o d
007 cr|nu||||||||
008 261011s2024 miu||||||m |||||||eng d
020 $a 9798384461111
035 $a (MiAaPQD)AAI31693775
035 $a (MiAaPQD)0799vireo565Collopy
035 $a AAI31693775
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Collopy, Rachel Matrenec, $e author. $3 3828562
245 1 0 $a Epigenetic Regulation of Hepatitis B Virus In Vivo / $c Rachel Matrenec Collopy.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (106 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-04, Section: B.
500 $a Advisors: Oberstein, Adam; McLachlan, Alan Committee members: He, Bin; Petukhov, Pavel; Federle, Michael.
502 $b Ph.D. $c University of Illinois at Chicago $d 2024.
520 $a Chronic hepatitis B virus (HBV) infection is a global public health concern responsible for nearly 1 million deaths annually. Current mainstays of HBV treatment, nucleoside analogs and interferon, are associated with drug resistance and negative side effects. Most importantly, these treatments are not curative and only slow the progression of chronic HBV, which frequently leads to significant liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Chronic HBV infection is maintained by viral covalently closed circular (ccc) DNA, a highly stable replication product and transcriptional template which exists as an episome in the nucleus. As such, the epigenetic silencing of nuclear HBV DNA represents one potential mechanism that may address curing chronic HBV infection. The limited coding capacity of the virus leaves few viral drug targets. As such, targeting host cellular factors that contribute to successful HBV replication is imperative. This current study explores the roles of Foxa and Ten-eleven translocation (Tet) methylcytosine dioxygenases in the epigenetic regulation of HBV DNA.Liver-specific Foxa- and Tet-deficient HBV transgenic mice are useful in vivo models of chronic HBV infection. HBV cccDNA is associated with histones and assembled into chromatin in patients. It is likely subject to regulation similar to that of the HBV transgene in this mouse model. Liver-specific Foxa-deficient HBV transgenic mice do not replicate HBV due to the specific transcriptional silencing of the viral DNA as a result of methylation. The methylation of the HBV DNA is observed in these mice regardless of which Foxa factor is deleted, suggesting that the level of Foxa factor activity governs the demethylation of the HBV transgene, rather than the expression of any specific Foxa factor. Similarly, Tet-deficient HBV transgenic mice display high levels of viral DNA methylation and very low levels of viral transcription and replication. Together, these observations suggest that Foxa and/or Tet enzymes are viable drug targets that may offer resolution of chronic HBV infection.
546 $a English
590 $a School code: 0799
650 4 $a Virology. $3 642304
650 4 $a Genetics. $3 530508
650 4 $a Microbiology. $3 536250
650 4 $a Immunology. $3 611031
653 $a Hepatitis B virus
653 $a Hepatocellular carcinoma
653 $a DNA methylation
653 $a Foxa
653 $a Epigenetic modification
690 $a 0720
690 $a 0369
690 $a 0982
690 $a 0410
710 2 $a University of Illinois at Chicago. $b Microbiology and Immunology. $e degree granting institution. $3 3828563
720 1 $a Oberstein, Adam $e degree supervisor.
720 1 $a McLachlan, Alan $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-04B.
790 $a 0799
791 $a Ph.D.
792 $a 2024
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31693775